1 Wall Street Analyst Thinks Editas Medicine Stock Is Going to $15. Is It a Buy Around $5?
usx:edit Blog PostThis 1 Problem Could Sink at Least 4 Gene-Editing Stocks
usx:edit usx:crsp usx:blue usx:ntla Blog PostWhy Shares of Bluebird Bio, CRISPR Therapeutics, and Editas Medicine Soared This Week
usx:edit usx:crsp usx:blue Blog PostWhat's Hot in the Stock Market?
usx:goog usx:googl usx:amzn usx:zm usx:mrk usx:gm usx:mkc usx:bbby usx:dltr usx:edit usx:shw usx:pubm usx:fivn usx:wrby Blog Post